These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7515405)

  • 1. Impact of special care unit for patients with advanced Alzheimer's disease on patients' discomfort and costs.
    Volicer L; Collard A; Hurley A; Bishop C; Kern D; Karon S
    J Am Geriatr Soc; 1994 Jun; 42(6):597-603. PubMed ID: 7515405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative fever management in Alzheimer patients. quality plus fiscal responsibility.
    Hurley AC; Volicer B; Mahoney MA; Volicer L
    ANS Adv Nurs Sci; 1993 Sep; 16(1):21-32. PubMed ID: 7508704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resource Use and Cost of Alzheimer's Disease in France: 18-Month Results from the GERAS Observational Study.
    Rapp T; Andrieu S; Chartier F; Deberdt W; Reed C; Belger M; Vellas B
    Value Health; 2018 Mar; 21(3):295-303. PubMed ID: 29566836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings.
    Wimo A; Reed CC; Dodel R; Belger M; Jones RW; Happich M; Argimon JM; Bruno G; Novick D; Vellas B; Haro JM
    J Alzheimers Dis; 2013; 36(2):385-99. PubMed ID: 23629588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective one-year cost-of-illness study in a cohort of patients with dementia of Alzheimer's disease type in Spain: the ECO study.
    Coduras A; Rabasa I; Frank A; Bermejo-Pareja F; López-Pousa S; López-Arrieta JM; Del Llano J; León T; Rejas J
    J Alzheimers Dis; 2010; 19(2):601-15. PubMed ID: 20110605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
    Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
    J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting short-term survival for patients with advanced Alzheimer's disease.
    Volicer BJ; Hurley A; Fabiszewski KJ; Montgomery P; Volicer L
    J Am Geriatr Soc; 1993 May; 41(5):535-40. PubMed ID: 8486888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic impact of Alzheimer's disease in the United Kingdom. Cost of care and disease severity for non-institutionalised patients with Alzheimer's disease.
    Souêtre E; Thwaites RM; Yeardley HL
    Br J Psychiatry; 1999 Jan; 174():51-5. PubMed ID: 10211151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of long-term acute-care facilities on the outcome and cost of care for patients undergoing prolonged mechanical ventilation.
    Seneff MG; Wagner D; Thompson D; Honeycutt C; Silver MR
    Crit Care Med; 2000 Feb; 28(2):342-50. PubMed ID: 10708164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Goals of care in advanced dementia: quality of life, dignity and comfort.
    Volicer L
    J Nutr Health Aging; 2007; 11(6):481. PubMed ID: 17985063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital-based palliative care consultation: effects on hospital cost.
    Penrod JD; Deb P; Dellenbaugh C; Burgess JF; Zhu CW; Christiansen CL; Luhrs CA; Cortez T; Livote E; Allen V; Morrison RS
    J Palliat Med; 2010 Aug; 13(8):973-9. PubMed ID: 20642361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study.
    Lenox-Smith A; Reed C; Lebrec J; Belger M; Jones RW
    BMC Geriatr; 2016 Nov; 16(1):195. PubMed ID: 27887645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Special care units for people with Alzheimer's disease. Only for the privileged few?
    Maas ML; Specht JP; Weiler K; Buckwalter KC; Turner B
    J Gerontol Nurs; 1998 Mar; 24(3):28-37. PubMed ID: 9611554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trials.
    Kahle-Wrobleski K; Fillit H; Kurlander J; Reed C; Belger M
    Eur J Health Econ; 2015 Dec; 16(9):995-1004. PubMed ID: 25410743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fever-management strategy on the progression of dementia of the Alzheimer type.
    Hurley AC; Volicer BJ; Volicer L
    Alzheimer Dis Assoc Disord; 1996; 10(1):5-10. PubMed ID: 8919491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the financial impact of an inpatient acute palliative care unit in a tertiary care teaching hospital.
    Albanese TH; Radwany SM; Mason H; Gayomali C; Dieter K
    J Palliat Med; 2013 Mar; 16(3):289-94. PubMed ID: 23343113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settings.
    Reese JP; Hessmann P; Seeberg G; Henkel D; Hirzmann P; Rieke J; Baum E; Dannhoff F; Müller MJ; Jessen F; Geldsetzer MB; Dodel R
    J Alzheimers Dis; 2011; 27(4):723-36. PubMed ID: 21876256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct and indirect cost of managing alzheimer's disease and related dementias in the United States.
    Deb A; Thornton JD; Sambamoorthi U; Innes K
    Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):189-202. PubMed ID: 28351177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease.
    Zhu CW; Scarmeas N; Torgan R; Albert M; Brandt J; Blacker D; Sano M; Stern Y
    Neurology; 2006 Sep; 67(6):998-1005. PubMed ID: 16914696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical management, costs, and consequences of Alzheimer's disease in Germany: an analysis of health claims data.
    Brüggenjürgen B; Andersohn F; Ezzat N; Lacey L; Willich S
    J Med Econ; 2015 Jun; 18(6):466-73. PubMed ID: 25692902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.